These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
7. Nucleic acids from intact epithelial cells as a target for stool-based molecular diagnosis of colorectal cancer. Spethmann S; Fischer C; Wagener C; Streichert T; Tschentscher P Int J Mol Med; 2004 Mar; 13(3):451-4. PubMed ID: 14767578 [TBL] [Abstract][Full Text] [Related]
8. [Problems and prospects of non-invasive screening for colorectal cancer]. Maev IV; Govorun VM; Kucheriavyĭ IuA; Golubev NN; Generozov EV; Maslov VV; LiubeznovA IIu; Kostin PA Klin Med (Mosk); 2009; 87(7):10-6. PubMed ID: 19705783 [TBL] [Abstract][Full Text] [Related]
9. Stool DNA screening for colorectal neoplasia: biological and technical basis for high detection rates. Berger BM; Ahlquist DA Pathology; 2012 Feb; 44(2):80-8. PubMed ID: 22198259 [TBL] [Abstract][Full Text] [Related]
10. Noninvasive testing for colorectal cancer: a review. Ouyang DL; Chen JJ; Getzenberg RH; Schoen RE Am J Gastroenterol; 2005 Jun; 100(6):1393-403. PubMed ID: 15929776 [TBL] [Abstract][Full Text] [Related]
11. Stool test for colorectal cancer screening: what is going on? Bonanno E; Rulli F; Galatà G; Pucci S; Sesti F; Farinon AM; Spagnoli LG Surg Oncol; 2007 Dec; 16 Suppl 1():S43-5. PubMed ID: 18055195 [TBL] [Abstract][Full Text] [Related]
12. Stool test for colorectal cancer screening--it's time to move! Loitsch SM; Shastri Y; Stein J Clin Lab; 2008; 54(11-12):473-84. PubMed ID: 19216253 [TBL] [Abstract][Full Text] [Related]
13. APC, K-ras, and p53 gene mutations in colorectal cancer patients: correlation to clinicopathologic features and postoperative surveillance. Hsieh JS; Lin SR; Chang MY; Chen FM; Lu CY; Huang TJ; Huang YS; Huang CJ; Wang JY Am Surg; 2005 Apr; 71(4):336-43. PubMed ID: 15943410 [TBL] [Abstract][Full Text] [Related]
14. Detection of stool DNA mutations before and after treatment of colorectal neoplasia. Syngal S; Stoffel E; Chung D; Willett C; Schoetz D; Schroy P; Jagadeesh D; Morel K; Ross M Cancer; 2006 Jan; 106(2):277-83. PubMed ID: 16342248 [TBL] [Abstract][Full Text] [Related]
15. Noninvasive detection through REMS-PCR technique of K-ras mutations in stool DNA of patients with colorectal cancer. Mixich F; Ioana M; Voinea F; Săftoiu A; Ciurea T J Gastrointestin Liver Dis; 2007 Mar; 16(1):5-10. PubMed ID: 17410282 [TBL] [Abstract][Full Text] [Related]
16. Testing for faecal calprotectin (PhiCal) in the Norwegian Colorectal Cancer Prevention trial on flexible sigmoidoscopy screening: comparison with an immunochemical test for occult blood (FlexSure OBT). Hoff G; Grotmol T; Thiis-Evensen E; Bretthauer M; Gondal G; Vatn MH Gut; 2004 Sep; 53(9):1329-33. PubMed ID: 15306594 [TBL] [Abstract][Full Text] [Related]
17. Reproducibility of a multitarget stool-based DNA assay for colorectal cancer detection. Brand RE; Ross ME; Shuber AP Am J Gastroenterol; 2004 Jul; 99(7):1338-41. PubMed ID: 15233675 [TBL] [Abstract][Full Text] [Related]
18. Testing of multiple samples increases the sensitivity of stool decay-accelerating factor test for the detection of colorectal cancer. Mizuno M; Mizuno M; Iwagaki N; Nasu J; Okazaki H; Yamamoto K; Okada H; Tsuji T; Fujita T; Shiratori Y Am J Gastroenterol; 2003 Nov; 98(11):2550-5. PubMed ID: 14638362 [TBL] [Abstract][Full Text] [Related]
19. Colorectal cancer screening using stool DNA analysis in clinical practice: early clinical experience with respect to patient acceptance and colonoscopic follow-up of abnormal tests. Berger BM; Schroy PC; Rosenberg JL; Lai-Goldman M; Eisenberg M; Brown T; Rochelle RB; Billings PR Clin Colorectal Cancer; 2006 Jan; 5(5):338-43. PubMed ID: 16512992 [TBL] [Abstract][Full Text] [Related]
20. Patient perceptions of stool-based DNA testing for colorectal cancer screening. Schroy PC; Heeren TC Am J Prev Med; 2005 Feb; 28(2):208-14. PubMed ID: 15710277 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]